Title:
USE OF SUBSTITUTED AMINOPROPIONATE COMPOUND IN TREATMENT OF SARS-COV-2 INFECTIONS
Document Type and Number:
WIPO Patent Application WO/2021/147236
Kind Code:
A1
Abstract:
The present invention relates to a substituted aminopropionate compound as represented by formula I, and a pharmaceutically acceptable salt thereof and/or a solvate thereof and/or a hydrate thereof, and a pharmaceutical composition containing the compound, wherein same are used for treating diseases or infections caused by SARS-CoV-2.
Inventors:
ZHONG WU (CN)
CAO RUIYUAN (CN)
XIAO GENGFU (CN)
HU ZHIHONG (CN)
WANG MANLI (CN)
ZHANG LEIKE (CN)
LI WEI (CN)
LI YUEXIANG (CN)
ZHAO LEI (CN)
FAN SHIYONG (CN)
LI SONG (CN)
CAO RUIYUAN (CN)
XIAO GENGFU (CN)
HU ZHIHONG (CN)
WANG MANLI (CN)
ZHANG LEIKE (CN)
LI WEI (CN)
LI YUEXIANG (CN)
ZHAO LEI (CN)
FAN SHIYONG (CN)
LI SONG (CN)
Application Number:
PCT/CN2020/097421
Publication Date:
July 29, 2021
Filing Date:
June 22, 2020
Export Citation:
Assignee:
ACAD OF MILITARY MEDICAL SCIENCES (CN)
International Classes:
A61K31/675; A61P11/00; A61P31/14
Foreign References:
| CN111265532A | 2020-06-12 | |||
| CN110636884A | 2019-12-31 | |||
| CN110636884A | 2019-12-31 |
Attorney, Agent or Firm:
CCPIT PATENT AND TRADEMARK LAW OFFICE (CN)
Download PDF: